Firy Inc. vs Zoetis Inc — how do they compare? Firy Inc. trades at $8.52 (market cap $125.48M), while Zoetis Inc trades at $76.23 (market cap $31.25B). The key difference: Zoetis Inc is far larger — about 249× Firy Inc.'s market cap, and Zoetis Inc pays a 2.84% dividend while Firy Inc. pays none. Which is the better fit depends on your goals.
| FIRY | ZTS | |
|---|---|---|
Market Cap | $125.48M | $31.25B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.45 | $156.76 |
52-Week Low | $2.28 | $71.91 |
Enterprise Value | $69.16M | $38.54B |
Dividend Yield | — | 2.84% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ZTS trades at $74.08, down 1.74% on the day, with a bearish technical signal from moving averages. The company reported strong 2025 results including $9.47B revenue, $2.67B net income, and a 28.03% net margin, but missed Q1 2026 EPS estimates. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU.
Despite near-term legal overhangs and a recent earnings miss, ZTS maintains robust profitability and a consensus price target of $101.43 implies significant upside. Key risks include litigation outcomes and competitive pressures in the companion animal segment, while solid cash flow and high ROE support long-term value.
Trailing returns across standard periods
Latest headlines on both assets
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →